Q32 Bio Inc. Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price
Q32 Bio Inc. (FIXX) reported Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price of $8.10 per share for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Notes › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice · last filed 2026-08-05
- Q32 Bio Inc. share-based compensation arrangements by share-based payment award, options, grants in period, weighted average exercise price for the quarter ending 2026-03-31 was $3.53, a 38.98% increase year-over-year.
- Q32 Bio Inc. share-based compensation arrangements by share-based payment award, options, grants in period, weighted average exercise price for the quarter ending 2025-03-31 was $2.54, a 86.89% decline year-over-year.
- Q32 Bio Inc. share-based compensation arrangements by share-based payment award, options, grants in period, weighted average exercise price for the quarter ending 2024-03-31 was $19.37, a 1110.63% increase year-over-year.
- Q32 Bio Inc. share-based compensation arrangements by share-based payment award, options, grants in period, weighted average exercise price for the quarter ending 2023-03-31 was $1.60, a 42.86% decline year-over-year.
- Q32 Bio Inc. share-based compensation arrangements by share-based payment award, options, grants in period, weighted average exercise price for fiscal 2024 was $17.27, a 1028.76% increase from fiscal 2023.
- Q32 Bio Inc. share-based compensation arrangements by share-based payment award, options, grants in period, weighted average exercise price for fiscal 2023 was $1.53, a 42.05% decline from fiscal 2022.
- Q32 Bio Inc. share-based compensation arrangements by share-based payment award, options, grants in period, weighted average exercise price for fiscal 2022 was $2.64, a 77.94% decline from fiscal 2021.
- Q32 Bio Inc. share-based compensation arrangements by share-based payment award, options, grants in period, weighted average exercise price for fiscal 2021 was $11.97, a 32.83% decline from fiscal 2020.
| Period end | Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price 3 month | Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price 6 month | Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price 9 month | Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price 12 month |
|---|---|---|---|---|
| 2026-06-30 | $8.10 10-Q · filed 2026-08-05 | |||
| 2026-03-31 | $3.53 10-Q · filed 2026-05-05 | |||
| 2025-09-30 | $2.36 10-Q · filed 2025-11-13 | |||
| 2025-06-30 | $2.54 10-Q · filed 2025-08-06 | |||
| 2025-03-31 | $2.54 10-Q · filed 2025-05-08 | |||
| 2024-12-31 | $17.27 10-K · filed 2025-03-11 | |||
| 2024-09-30 | $17.16 10-Q · filed 2024-11-07 | |||
| 2024-06-30 | $17.09 10-Q · filed 2024-08-08 | |||
| 2024-03-31 | $19.37 10-Q · filed 2024-05-09 | |||
| 2023-12-31 | $1.53 10-K · filed 2024-03-13 | |||
| 2023-09-30 | $1.53 10-Q · filed 2023-11-14 | |||
| 2023-06-30 | $1.53 10-Q · filed 2023-08-14 | |||
| 2023-03-31 | $1.60 10-Q · filed 2023-05-11 | |||
| 2022-12-31 | $2.64 10-K · filed 2023-03-09 | |||
| 2022-09-30 | $2.70 10-Q · filed 2022-11-10 | |||
| 2022-06-30 | $2.71 10-Q · filed 2022-08-15 | |||
| 2022-03-31 | $2.80 10-Q · filed 2022-05-16 | |||
| 2021-12-31 | $11.97 10-K · filed 2022-03-23 | |||
| 2021-09-30 | $12.39 10-Q · filed 2021-11-15 | |||
| 2021-06-30 | $12.84 10-Q · filed 2021-08-12 | |||
| 2021-03-31 | $13.81 10-Q · filed 2021-05-06 | |||
| 2020-12-31 | $17.82 10-K · filed 2021-03-11 | |||
| 2020-09-30 | $18.43 10-Q · filed 2020-11-09 | |||
| 2020-06-30 | $19.29 10-Q · filed 2020-08-10 | |||
| 2020-03-31 | $21.40 10-Q · filed 2020-05-07 | |||
| 2019-12-31 | $21.60 10-K · filed 2020-03-12 | |||
| 2019-09-30 | $24.36 10-Q · filed 2019-11-12 | |||
| 2019-06-30 | $25.02 10-Q · filed 2019-08-08 | |||
| 2019-03-31 | $25.95 10-Q · filed 2019-05-13 | |||
| 2018-12-31 | $19.05 10-K · filed 2019-03-12 | |||
| 2018-09-30 | $16.09 10-Q · filed 2018-11-13 | |||
| 2018-06-30 | $15.96 10-Q · filed 2018-08-13 | |||
| 2018-03-31 | $15.71 10-Q · filed 2018-05-14 |